MSD
High-Throughput MSD Assays with Unmatched Speed and Quality
Dash’s MSD platform delivers highly consistent, flexible, and scalable assay execution with unmatched speed and unprecedented quality. With integrated plate washing, reading, incubating, and shaking, we can efficiently execute MSD assays to support applications such as PK, PD, ADA, biomarkers, and cytokine panels.
Our platform is optimized for MSD readouts in both 96- and 384-well plate formats. We offer development of fully custom MSD assays or rapid implementation of existing vendor kits, and we also provide pre-developed MSD kits for common analytes, including multiplex cytokine panels.
An official MSD partner, Dash is deeply experienced in end-to-end assay development, optimization, and high-throughput execution. Our scientists bring extensive expertise across therapeutic areas and sample types, enabling us to tailor workflows for even the most challenging study designs. From exploratory biomarker discovery through late-stage clinical support, we deliver actionable, reproducible data that accelerate decision-making and de-risk development programs.
Accelerated MSD Assay Execution with a Highly Automated Bioanalysis CRO
At Dash Bio, we specialize in delivering MSD assay services with unmatched speed, sensitivity, and precision. As a highly automated bioanalysis CRO, we streamline every stage of assay development and execution—from sample intake to data delivery—so you can accelerate decision-making and keep your programs on track.
Our automation-first approach to MSD assays ensures consistency, reproducibility, and dramatically shortened timelines for the studies that matter most. Whether you are measuring biomarkers, evaluating large molecule pharmacokinetics (PK), conducting ADA testing, or analyzing small molecule drug candidates, our MSD assay platforms are optimized to generate high-quality, reliable results with industry-leading turnaround times. By integrating robotics, advanced liquid handling, and intelligent workflows, we eliminate bottlenecks common to traditional CROs, enabling your team to access critical bioanalytical data faster.
With deep expertise in MSD assay development and bioanalysis CRO services spanning early discovery through clinical development, Dash Bio understands the unique requirements of MSD-based biomarker assays across therapeutic areas. Our scientists bring rigor and scalability to every project, leveraging multiplexing capability, ultrasensitive detection, and automated precision to deliver data that is not only faster, but also more reproducible and trustworthy.
When timelines are critical, you need a partner who combines scale with quality. As an official MSD partner CRO, Dash Bio is redefining the standard for MSD assay execution by pairing assay development expertise with next-generation automation. The result: a proven solution to accelerate studies, de-risk development pipelines, and keep your programs advancing at the pace of innovation.